Firm battles venous disease and ulcers

Venari Medical is testing a device that could help millions with varicose veins, writes Trish Dromey

Galway startup Venari Medical is preparing to conduct human trials of a medical device that is designed to be the first in the world to use the body’s natural response to treat varicose veins and venous ulcers. Raising €3m to fund a first human trial next year, Venari plans to launch in the US market in 2022, targeting a market opportunity in the US and Europe for the treatment of chronic venous disease estimated to be worth €2bn.